https://www.ibtomato.com/ExternalView.aspx?type=1&no=19187IB토마토ko2026-08-12T16:08:29+09:00(멈춰선 원화코인)①법안 계류 1년…은행권 '51% 룰' 선점전https://www.ibtomato.com/ExternalView.aspx?type=1&no=19185IB토마토ko2026-08-12T15:53:47+09:00SK디앤디, 유증 전 '유동성 고비'…1320억 자구계획 성패가 변수https://www.ibtomato.com/ExternalView.aspx?type=1&no=19188IB토마토ko2026-08-12T15:52:23+09:00(스튜어드십 10년)①참여기관 265곳 시대…이제는 '숫자보다 행동'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19192IB토마토ko2026-08-12T17:34:48+09:00현대차, 전기차 이어 로봇도 '중국 벽'…BD 적자 1.8조https://www.ibtomato.com/ExternalView.aspx?type=1&no=19186IB토마토ko2026-08-12T15:35:05+09:00넥스트바이오, 글로벌 임상 순항…'한계기업' 꼬리표 뗄까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19214IB토마토ko2026-08-13T18:32:54+09:00키움PE, 풀무원 CB 1000억 중 600억 회수…400억은 주가가 변수https://www.ibtomato.com/ExternalView.aspx?type=1&no=19180IB토마토ko2026-08-12T15:25:43+09:00(녹색철강 청구서)②원가 뛰고 단가 막혀…저탄소 투자 동력 약화https://www.ibtomato.com/ExternalView.aspx?type=1&no=19182IB토마토ko2026-08-12T10:45:40+09:00계열사 돈 3조 얽힌 오케이금융…예별손보 정상화 '의문'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19190IB토마토ko2026-08-12T17:42:10+09:00컴투스, 310억 메타버스 실험 축소…남은 자금은 IP 투자로https://www.ibtomato.com/ExternalView.aspx?type=1&no=19030IB토마토ko2026-08-12T06:00:00+09:00(데스크&피플)허성무 더불어민주당 의원https://www.ibtomato.com/ExternalView.aspx?type=1&no=19210IB토마토ko2026-08-13T17:45:58+09:00(단독)효성, 첫 중장기 배당 가이드라인 만든다…지주사 할인 깰까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19213IB토마토ko2026-08-13T17:37:42+09:00(공시톺아보기)공정거래 자율준수 공시, 왜 자발적으로 할까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19207IB토마토ko2026-08-13T17:30:00+09:00(합정역 7번출구)국민연금 더 내는데…'고갈' 걱정은 왜 계속될까https://www.ibtomato.com/ExternalView.aspx?type=1&no=19205IB토마토ko2026-08-13T17:05:29+09:00기후보험 법적 기반 마련…국가재보험이 활성화 '열쇠'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19204IB토마토ko2026-08-13T16:43:46+09:00(IPO클립)해치텍, 경쟁률 102대 1에도 공모가 하단…'반쪽 흥행'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19194IB토마토ko2026-08-13T15:53:21+09:00엘앤씨바이오, 최대 실적에도 1406억 유증…CB 리스크 털어낸다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19203IB토마토ko2026-08-13T11:01:51+09:00(크레딧시그널)한온시스템, 재무 체력 회복했지만…차입금 2조 부담https://www.ibtomato.com/ExternalView.aspx?type=1&no=19178IB토마토ko2026-08-11T17:14:53+09:00SK디앤디, 분양수입 70% 급감…지산 부진에 실적 변동성 확대https://www.ibtomato.com/ExternalView.aspx?type=1&no=19179IB토마토ko2026-08-11T16:56:08+09:00카카오, 지배구조 개편 2년 만에 성과…이익 체력 커졌다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19171IB토마토ko2026-08-11T16:24:34+09:00(사라진 BBB)①공모채서 밀려난 BBB…연말 차환 앞두고 '양극화'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19181IB토마토ko2026-08-12T11:05:05+09:00에스엠씨지, 이익 늘고 현금 줄고…재고·매출채권 급증https://www.ibtomato.com/ExternalView.aspx?type=1&no=19167IB토마토ko2026-08-11T16:01:30+09:00워트, 설비투자 1억도 안 되는데…배당은 32억https://www.ibtomato.com/ExternalView.aspx?type=1&no=19196IB토마토ko2026-08-12T18:36:37+09:00동일기연, 영업익 5억인데 순익 64억…주식 평가익이 견인https://www.ibtomato.com/ExternalView.aspx?type=1&no=19170IB토마토ko2026-08-11T15:37:41+09:00케이뱅크, 금리 인상 '양날의 검'…이자수익 늘고 부실 위험도https://www.ibtomato.com/ExternalView.aspx?type=1&no=19173IB토마토ko2026-08-11T14:25:17+09:00페니트리움바이오, 유증 82억 줄었다…R&D 예산도 '직격탄'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19163IB토마토ko2026-08-11T14:03:50+09:00쌍용건설, 결손 털었지만…현금창출력 회복은 더뎌https://www.ibtomato.com/ExternalView.aspx?type=1&no=19177IB토마토ko2026-08-12T10:25:37+09:00투썸이 스타벅스 이겼다?…카드 결제액의 '착시'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19168IB토마토ko2026-08-11T11:20:53+09:00IBK투자증권, IPO 단독주관 늘렸지만…수익화 '관건'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19200IB토마토ko2026-08-12T17:55:19+09:00(크레딧시그널)대신증권, 실적 두 배 뛰었지만…시장지위는 '아직'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19193IB토마토ko2026-08-12T17:09:26+09:00(공시톺아보기)8월마다 쏟아지는 '하도급대금 공시' 뭐길래https://www.ibtomato.com/ExternalView.aspx?type=1&no=19189IB토마토ko2026-08-12T14:46:37+09:00(크레딧시그널)키움캐피탈, 포트폴리오 성장에 운용도 '성공' https://www.ibtomato.com/ExternalView.aspx?type=1&no=19184IB토마토ko2026-08-12T10:34:57+09:00그래피, 몸집 2.7배 레이 인수…잠재 신주 30% 부담https://www.ibtomato.com/ExternalView.aspx?type=1&no=19183IB토마토ko2026-08-12T09:21:15+09:00(데스크칼럼)루키 없는 '루키리그'